They have a very good path.
Just have taken too long, investors got fatigued and disappointed. They should have paid more attention to previous implantation studies in the US and potentially avoided the problems.
But if it they can proceed, they have a potential pipeline no-one else has. Their animal studies suggest NTcell could work for dementia. In a world of many big multi-billion dollar dementia treatment failures...
My connection, page-19
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
